Woodley Farra Manion Portfolio Management’s Ionis Pharmaceuticals IONS Stock Holding History

Woodley Farra Manion Portfolio Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,200	Closed	-$71K	–	235
2020 Q2	$71K	Sell	1,200 -3,067	-72%	-$171K	0.01%	140
2020 Q1	$202K	Hold	4,267	–	–	0.02%	76
2019 Q4	$258K	Buy	4,267 +200	+5%	+$11.9K	0.02%	78
2019 Q3	$244K	Hold	4,067	–	–	0.02%	71
2019 Q2	$261K	Sell	4,067 -88	-2%	-$6.22K	0.03%	73
2019 Q1	$337K	Buy	+4,155	New	+$268K	0.04%	68

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Woodley Farra Manion Portfolio Management's IONS Position: Q3 2020 in Review

Woodley Farra Manion Portfolio Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2020, closing a stake of 1,200 shares — an estimated $71K sold.

Woodley Farra Manion Portfolio Management first reported a position in IONS in Q1 2019 and held it in 6 quarters. The position peaked at $337K in Q1 2019. 368 funds tracked by Wall St. Rank hold IONS as of Q3 2020.

Woodley Farra Manion Portfolio Management reported no remaining Ionis Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Woodley Farra Manion Portfolio Management sold 1,200 Ionis Pharmaceuticals shares in Q3 2020, an estimated $71K.
Woodley Farra Manion Portfolio Management first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 6 quarters.
Woodley Farra Manion Portfolio Management's Ionis Pharmaceuticals position peaked at $337K in Q1 2019.
368 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2020.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q3 2020, filed 5 Nov 2020.